Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 8 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

MANNITOL - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Mannitol is a polyol (sugar alcohol) widely used in the food and pharmaceutical industries because of its unique functional properties. Mannitol is the generic name for a Food and Drug Administration (FDA) approved drug used as an osmotic diuretic and a mild renal vasodilator. Mannitol is typically administered intravenously, but can also be taken orally, depending on the purpose. Intravenously, it is used to treat excessive intracranial pressure, oliguria, and to expand openings in the blood-brain barrier. Orally, mannitol is used a sweetening agent in confections for people with diabetes and, in higher concentrations, as a laxative for children. It is also used as an anti-caking & free flow agent. Mannitol is non-cariogenic and has a low caloric content. Mannitol occurs as an odorless, sweet-tasting, white, crystalline powder with a melting range of 165° - 168° and a pKa of 3.4. One gram is sol¬uble in about 5.5 ml of water (at 25°) and it is very slightly soluble in alcohol. It is an isomer of sorbitol and is typically produced today by the hydrogenation of specialty glucose syrups. Mannitol is commercially available in variety of powder and granular forms. Mannitol is used as the dust that coats chewing gum, where it keeps the gum from absorbing moisture and getting sticky. This is due to its humectant (moisture trapping) properties, and very low hydroscopicity (does not attract moisture from the air). Mannitol is mostly produced in parallel to the sorbitol production and in fact, it is a co-product along with sorbitol. While sorbitol production is followed from starch, mannitol can be produced using sugar as base material. Commercially, D-Mannitol is obtained by the reduction of invert sugar. Mannitol is not presently produced in the country. It is imported from outside. The demand growth rate is around 7 to 8% per annum. The present Indian demand was around 2100 tonnes per annum for the last year. Currently, there are over a dozen units engaged in manufacture of intravenous fluids in the country with combined capacity of more than 1000 million bottles per annum. The Indian demand for IV fluids is around 500 million bottles per annum. Coming to global demand it is around 60000 tonnes per annum. The demand for mannitol is likely to go up steadily in the coming years, in view of the expected growth of the healthcare. As there is no production of mannitol at present in India, there is an ample space for new entrepreneurs to venture into this sector.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

QUININE SULPHATE FROM CINCHONA BARK - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

Quinine sulfate belongs to the anti-malarial category of drugs and it is the sulfate of an alkaloid obtained from the bark of species of Cinchona. The bark of cinchona produces several alkaloids. The most important alkaloid, quinine, has certain febrifuge properties. Of 38 species of cinchona, four species have economic value for the production of quinine: C. calisaya, C. legeriana, C. officianalis and C. succirubra. It contains not less than 99 percent and not more than 101 percent of total alkaloid salt, calculated as (C20H24N2O2)2•H2SO4, on the anhydrous basis. Cinchona trees remain the only practical source of quinine. Cinchona is a genus of tropical evergreen trees and shrubs, belonging to the family Rubiaceae. Not all species of cinchona can be used to produce quinine. Quinine is the chief alkaloid of cinchona bark (known as 'Fever Bark'), a tree found in South America. It is a natural white crystalline alkaloid having antipyretic (fever-reducing), antimalarial, analgesic (painkilling), anti-inflammatory properties and a bitter taste. It is a stereoisomer of quinidine which, unlike quinine, is an anti-arrhythmic. Quinine contains two major fused-ring systems: the aromatic quinoline and the bicyclic quinuclidine. In 1820, Pelletier and Caventou isolated quinine and cinchonine from cinchona. Though it has been synthesized in the lab, the bark of the cinchona tree is the only known natural source of quinine. Even today, quinine is obtained entirely from the natural sources due to the difficulties in synthesizing the complex molecule. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. The growth has been driven by many factors, such as legislative reforms, growth in contract manufacturing and outsourcing, value added foreign acquisitions and joint ventures and India's acu-men and expertise in reverse engineering of patented drug molecules. India has, in the meantime, been trying to comply with the World Trade Organization's Trade Related Intellectual Property Agreement (TRIPs) obligations. There is a very good scope for new entrepreneurs in this sector.
Plant capacity: 60 MT/AnnumPlant & machinery: 497 Lakhs
Working capital: -T.C.I: Cost of Project : 747 Lakhs
Return: 45.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

GLYCERIN - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Glycerin is a simple polyol compound. It is a colorless, odorless, viscous liquid that is widely used in pharmaceutical formulations. Glycerol has three hydrophilic hydroxyl groups that are responsible for its solubility in water and its hygroscopic nature. The glycerol backbone is central to all lipids known as triglycerides. Glycerol is sweet-tasting and of low toxicity. Glycerin is a 3 carbon polyol. It is an inevitable constituent of all animal and vegetable oils and fats. It is a product with many applications in pharmaceuticals and cosmetics. It is also a chemical intermediary in adhesives, tensio-actives and explosives. It is extracted chemically from castor oil before cracking. Glycerin is also a by-product in soap and oleochemical production, using natural fats and oils as raw materials or as a by-product in biodiesel production, during transesterification of vegetable oils into methyl esters. It is a clear, water-white, viscous, sweet tasting hygroscopic liquid. Crude glycerine is an essential by-product obtained from the manufacture of soaps, fatty acids, fatty alcohols and fatty acids methyl esters. After refining, glycerine will be used in many applications which cover pharmaceutical, cosmetics/toiletries, resins, cellulose films, paper, polyols, tobacco, food and drink, esters, nitration and other chemical uses and applications. Glycerin is an important raw material used in the manufacture of synthetic resins, namely alkyd resins and explosives. It is also used in the manufacture of lubricants, drugs, plasticizers, etc. In foods and beverages, glycerol serves as a humectant, solvent and sweetener, and may help preserve foods. It is also used as filler in commercially prepared low-fat foods and as a thickening agent in liqueurs. Glycerol is also used to manufacture mono- and di-glycerides for use as emulsifiers, as well as polyglycerol esters going into shortenings and margarine. The market for glycerine in domestic and international market is good. Some of the highest quality glycerin produced in the world is supplied by Malaysia and Indonesia. Glycerine competes in the market with other products such as sorbitol, glycols and many polyols from petrochemical feedstocks. If glycerine prices drop dramatically, also these products will be confronted with the unfair competitive situation created by the reduction in excise duties. Price of glycerin has increased in recent times,largely due to increase in vegetable oil prices. The forecast growth for glcerine is around 2.2% per year, driven mainly by personal care and food products. Good solubility, taste and lower pricing give glycerin an edge on sorbitol in toothpastes and mouth washes. Glycerin is used in food products either directly or as one of its derivatives, such as glycerol mono-stearate. The demand for glycerin in the food sector is growing as a result of the continuing trend toward lowering the fat content in foods. There is a very good scope for this product and new entrepreneurs should venture into this field.
Plant capacity: ---Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

MAIZE & ITS BY-PRODUCTS - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Maize is one of the main cereal grains which is produced throughout India and is placed 3rd position in agricultural base production though it is not our staple basic food. Maize is constituted by hull, germ, protein, starch and moisture. Maize is generally processed using the dry and wet milling processes. There is dry and wet milling process for manufacturing of by products such as starch, zein, germ and hulls. Starch is used in the manufacture of number of products such as starch esters, starch phosphates, glucose, dextrose, sorbitol, ethyl alcohol etc. Starch is the basic constituent of maize and it is converted to liquid glucose by adopting series of digestion steps on starch. It will be basically enzyme and acid digestion system. It may be enzyme - enzyme system or only acid digestion system. In the production of liquid glucose there is some production of dextrose anhydride. India is the fifth largest producer of maize in the world contributing 3% of the global production. In India, maize is grown in all seasons i.e., kharif, Rabi and summer. Of these three seasons, nearly 90% of the production is from kharif season, 7 to 8% during Rabi season and remaining 1 to 2% during summer season. Since the maize is rain dependent, it is mainly grown during kharif season. Presently, in India, maize is mainly used for preparation of poultry feed and extraction of starch. Out of total arrivals to the mandis nearly 75% of the produce is bought by the poultry feed manufacturers and 20% is purchased by the starch extractors. The wet milling industry in India is limited to certain pockets such as Gujarat, Maharashtra, Madhya Pradesh, Punjab, Karnataka and Chhattisgarh. There are about 17 wet milling units with a crushing capacity of about 3400 MT of maize/day. Gujarat is the largest producer of starch, having six units with a total crushing capacity of 1350 MT of maize per day, followed by Maharashtra with 5 units and capacity of 1050 MT and Madhya Pradesh with 3 units and capacity of 450 MT maize. There is a good scope to venture into this field for new entrepreneurs. Few Indian Major Players are as under: Anil Products Ltd. Anil Starch Products Ltd. Bharat Starch Inds. Ltd. English Indian Clays Ltd. Gayatri Bioorganics Ltd. Gujarat Ambuja Exports Ltd. Gujarat Ambuja Proteins Ltd. Gulshan Polyols Ltd. Indian Maize & Chemicals Ltd. International Bestfoods Ltd. K G Gluco Biols Ltd. Kamala Sugar Mills Ltd. Karnataka State Agro Corn Products Ltd. Laxmi Starch Ltd. Origin Agrostar Ltd. Pondicherry Agro Service & Inds. Corpn. Ltd. Rai Agro Inds. Ltd. Riddhi Siddhi Gluco Biols Ltd. Santosh Starch Ltd. Santosh Starch Products Ltd. Sayaji Industries Ltd. Sukhjit Starch & Chemicals Ltd. Tirupati Starch & Chemicals Ltd. Unique Sugars Ltd. Universal Starch-Chem Allied Ltd. Wockhardt Health Care Ltd. Cost Estimation: Capacity : 5250 MT/Annum Starch 1125 MT/Annum Liquid Glucose 4500 MT/Annum Dextrose Monohydrous 562 MT/Annum Oxidised Starch 900 MT/Annum Hull 1800 MT/Annum Zien 1050 MT/Annum Germ as by Products
Plant capacity: -Plant & machinery: 179 Lakhs
Working capital: -T.C.I: Cost of Project : 543 Lakhs
Return: 43.00%Break even: 59.00%
Add to Inquiry Add to Inquiry Basket

PHARMACEUTICAL GRADE SUGAR - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Pharmaceutical grade sugar can be manufactured by using cane beet or sugar cane itself. This is the more pure form of sugar may not contain sulphur and heavy toxic material like lead arsenic and mercury etc. This is used mainly in preparation of pharmaceutical and food products. There are few companies in organized sector manufacturing pharmaceutical grade sugar. Dhampur is one of the leading manufacturers. There is good domestic as well as export market for the pharma grade sugar. It can be concluded that there is a very good scope for new entrepreneurs if they produce the product with European competitive price.
Plant capacity: 15000 MT/AnnumPlant & machinery: 293 Lakhs
Working capital: -T.C.I: Cost of Project : 613 Lakhs
Return: 45.00%Break even: 53.00%
Add to Inquiry Add to Inquiry Basket

Gelatin Sponge - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economic

Gelatin sponge is a sterile compressed sponge has haemostatic properties and in precisely used for controlling bleeding. By virtue of its versatile usage for haemostatic function in dental treatment, in gaining eminence and being a innovative product, its demand is increasing day by day. In view of the horizons of its field of application, the future scope of this product is also bright. To cope up with the increasing demand of gelatin sponge, the imperative need of the hour is to set up more number of units for its manufacture. Thus, in the limelight of the facts enumerated above, a new entrepreneur can venture into this field. It is a lucrative project with bright scope.
Plant capacity: 6000000 Nos./AnnumPlant & machinery: 91 Lakhs
Working capital: -T.C.I: Cost of Project : 269 Lakhs
Return: 46.00%Break even: 49.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet, Syrup & Injectables) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunity

The Indian pharmaceutical industry today is in the front rank of India’s science based industry with wide ranging capabilities in the complex field of drugs manufacture and technology. The Indian pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the share. It is an extremely fragmented market with severe price competition and govt. price control. The pharmaceutical industry, with its rich scientific talents and research capabilities, supported by intellectual property protection regime is well set to take on the international market. The demand of pharmaceutical products are increasing very fast. So, any new entrepreneur can venture in to this field. Few Indian Major Players are as under: A C E Laboratories Ltd. A Tosh & Sons (India) Ltd. Abbott India Ltd. Adinath Bio-Labs Ltd. Advik Laboratories Ltd. Agio Pharmaceuticals Ltd. Alchem International Ltd. Alchemist Ltd. Alembic Ltd. Alintosch Pharmaceuticals Ltd. Alkem Laboratories Ltd. Alps Hospital Pvt. Ltd. Alved Pharma & Foods Pvt. Ltd. Ambalal Sarabhai Enterprises Ltd. American Remedies Ltd. Amol Pharmaceuticals Pvt. Ltd. Andre Laboratories Ltd. Anil Bioplus Ltd. Anil Starch Products Ltd. Ankur Drugs & Pharma Ltd. Apex Laboratories Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B A & Brothers (Eastern) Ltd. Bengal Chemicals & Pharmaceuticals Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Bio-Ethicals Pharma Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Bliss G V S Pharma Ltd. Brabourne Enterprises Ltd. Brawn Biotech Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caldern Pharmaceuticals Ltd. Casil Industries Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cipla Ltd. Concept Pharmaceuticals Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Croslands Research Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dolphin Laboratories Ltd. Dorcas Market Makers Ltd. Duchem Laboratories Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Endo Labs Ltd. Esskay Pharmaceuticals Ltd. Eupharma Laboratories Ltd. F D C Ltd. Fem Care Pharma Ltd. Flamingo Pharmaceuticals Ltd. Franco-Indian Pharmaceuticals Pvt. Ltd. Fredun Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. [Merged] Glaxosmithkline Pharmaceuticals Ltd. Glenmark Generics Ltd. Glenmark Pharmaceuticals Ltd. Global Spin-Weave Ltd. Gufic Biosciences Ltd. H & B Stores Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Bio-Pharmaceutical Corpn. Ltd. Harshita Ltd. Hindustan Antibiotics Ltd. Icpa Health Products Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. John Wyeth (India) Ltd. Jubilant Life Sciences Ltd. Kamala Sugar Mills Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kopran Ltd. Larite Industries Ltd. Lawacoated Papers Pvt Ltd. Lekar Pharma Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka Labs Ltd. M J Pharmaceuticals Ltd. Magnet Labs Pvt. Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Mankind Pharma Ltd. Matrix Laboratories Ltd. Max Healthcare Institute Ltd. Mayo (India) Ltd. Medispan Ltd. Meher Pharma (India) Ltd. Merck Ltd. Micro Labs Ltd. Midas Pharmasec Ltd. Millennium Laboratories Ltd. Nadukkara Agro Processing Co. Ltd. Neelkanth Technologies Ltd. Neon Laboratories Ltd. Norris Medicines Ltd. Omega Laboratories Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Ortin Laboratories Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panjon Ltd. Parbhudas Kishordas Tobacco Products Pvt. Ltd. Parenteral Drugs (India) Ltd. Parle Bisleri Pvt. Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfizer Ltd. Phar-East Laboratories Ltd. Pharmed Ltd. Plethico Pharmaceuticals Ltd. Psychotropics India Ltd. Pure Health Products Pvt. Ltd. Pure Pharma Ltd. R P G Life Sciences Ltd. Radicura & Co. Ltd. Rajat Pharmachem Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Rekvina Laboratories Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rusan Pharma Ltd. S O L Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarthi Pharmaceuticals Ltd. Sayaji Industries Ltd. Sekhsaria Chemicals Ltd. Silver Oak (India) Ltd. Smith Stanistreet Pharmaceuticals Ltd. Solvay Pharma India Ltd. Standard Pharmaceuticals Ltd. State Trading Corpn. Of India Ltd. Stellar Exports Ltd. Strides Arcolab Ltd. Strides Specialties Pvt. Ltd. Surya Pharmaceutical Ltd. Suyash Laboratories Ltd. Themis Medicare Ltd. Torrent Pharmaceuticals Ltd. Trans Medicare Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unimed Investments Ltd. Unique Sugars Ltd. United Breweries (Holdings) Ltd. Vellanova Pharmaceuticals Ltd. Venus Remedies Ltd. Vera Pharma Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wanbury Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. Win Laboratories Pvt. Ltd. Winmac Laboratories Ltd. Wockhardt Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Pharmacy Ltd. Zenotech Laboratories Pvt. Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd. Cost Estimation: Capacity : 9000000 Nos./Annum (Bruphen Tablets) 900000 Bottles/Annum (Paracetamol Syrup) 1200000 Bottles/Annum (Dextrose Saline) 1800000 Nos./Annum (Streptomycine Injection)
Plant capacity: -Plant & machinery: 85 Lakhs
Working capital: -T.C.I: Cost of Project : 350 Lakhs
Return: 42.00%Break even: 56.00%
Add to Inquiry Add to Inquiry Basket

Glycerine - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Glycerine is known as glycerol. Glycerol combined with fatty acids in the form of easters known as the glycerides is universally distributed and functions in the development and reproduction of all plant and animal life. Glycerol plays an important part as an intermediary product in the metabolism of the living organism but seldom remains in the free state in natural products. It is generally agreed that in plants glycerol and the glycerides originate from carbohydrates produced by photosynthesis from carbon dioxide and water. Glycerine was first discovered in 1779 by Scheele who heated a mixture of litharage and olive oil and extracted it with water. Glycerine is used in nearly every industry. Glycerine has wide applications in drugs and pharmaceuticals, cosmetics, in food products, in tobacco etc. Besides these, glycerine is also used as lubricant and used in manufacture of alkyd resins and explosives. It also used in textile industry and in tooth paste. Glycerine is used in cream and lotion based cosmetic to keep the skin soft and moisture. Glycerine is a greasy, so it also used in lip-stick, chip-stick, lip gloves etc. It is used in flavouring and coloring food products. It is generally obtained as a byproduct from manufacture of soaps and fatty acids. Glycerine enjoys very wide use in various industries because of its chemical and physical properties. Glycerin competes in the market with other products such as sorbitol, glycols and many polyols from petrochemical feedstocks. If and when there would be drop in price of glycerin due to over supply scenario, perhaps glycerin would become competitive with other products such as sorbitol and may be able to penetrate the market for sorbitol and polyols. It has good domestic and export demand, so there is a very good scope in this sector and new entrepreneurs should venture into this field. Few Indian Major Players are as under: Adi Finechem Ltd. Foods, Fats & Fertilisers Ltd. Godrej Consumer Products Ltd. Godrej Industries Ltd. Golden Agro Tech Inds. Ltd. Gujarat Godrej Innovative Chemicals Ltd. [Erstwhile] Hindustan Unilever Ltd. Ind Barath Commodities Ltd. Jocil Ltd. Micron Chemicals Ltd. Nirma Ltd. Organic Chemoils Ltd. Ritesh International Ltd. Southern Online Bio Technologies Ltd. Sree Rayalaseema Alkalies & Allied Chemicals Ltd. Sudha Agro Oil & Chemical Inds. Ltd. Tata Oil Mills Co. Ltd. [Merged] Wipro Ltd.
Plant capacity: 1 Ton/DayPlant & machinery: 51 Lakhs
Working capital: -T.C.I: 174 Lakhs
Return: 40.00%Break even: 43.00%
Add to Inquiry Add to Inquiry Basket

Maize Starch & Liquid Glucose - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Starch is a group of polysaccharides, composed of glucopyranose units joined together by glucosidric linkages. It conforms to the molecular formula. Where a varies from a few hundred to over one million. Starch is found as the reserve carbohydrate in various parts of plants and is enzymetically broken down to glucose to other carbohydrates according to the metabolic needs of the plants. Starch has many industrial applications. These include (a) Textile Industry (b) Food Industry (c) Paper Industry (d) Pharmaceutical Industry (e) Manufacture of modified starch. Liquid Glucose produced in India is consumed by the confectionery industry. It is used also in textile printing and in biscuit and canning industries, tanning and tobacco curing. This is used in leather, textile, pharmaceutical and other industries. The history of starch industry dates back to early forties. There are few units at present in the country producing starch from maize and three units producing starch from Tapioca in the organized sector. There is bright market potential for maize starch and liquid glucose. New entrepreneurs can venture into this field. Few Indian Major Players are as under: Anil Products Ltd. Anil Starch Products Ltd. [Merged] Bharat Starch Inds. Ltd. [Merged] English Indian Clays Ltd. Gayatri Bioorganics Ltd. Gujarat Ambuja Exports Ltd. Gujarat Ambuja Proteins Ltd. [Merged] Gulshan Polyols Ltd. Indian Maize & Chemicals Ltd. International Bestfoods Ltd. [Merged] K G Gluco Biols Ltd. [Merged] Kamala Sugar Mills Ltd. Karnataka State Agro Corn Products Ltd. Laxmi Starch Ltd. Origin Agrostar Ltd. Pondicherry Agro Service & Inds. Corpn. Ltd. Rai Agro Inds. Ltd. Riddhi Siddhi Gluco Biols Ltd. Santosh Starch Ltd. Santosh Starch Products Ltd. Sayaji Industries Ltd. Sukhjit Starch & Chemicals Ltd. Tirupati Starch & Chemicals Ltd. Unique Sugars Ltd. Universal Starch-Chem Allied Ltd. Wockhardt Health Care Ltd. [Merged] Cost Estimation: Capacity : Maize Starch 22312 MT/Annum Liquid Glucose 8925 MT/Annum Germ (Bye Product) 1785 MT/Annum Fibre (Bye Product) 892 MT/Annum Steep Water (Bye Product) 2677 MT/Annum
Plant capacity: -Plant & machinery: 1477 Lakhs
Working capital: -T.C.I: Cost of Project : 2425 Lakhs
Return: 41.00%Break even: 44.00%
Add to Inquiry Add to Inquiry Basket

PHARMACEUTICAL MANUFACTURING UNIT (TABLET, SYRUP & INJECTABLS) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industry with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market, with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. Tablets are unit dosage forms that provide an accurate, stable dose with greatest precision and least content variability. Tablets are easy to use, handle and carry by the patient. Tablets are attractive and elegant in appearance. Tablets are the most stable dosage form with respect to their physical, chemical and microbiological attributes. The manufacturing cost of tablets is low as compared to other dosage form and their manufacturing speed is also quite high. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. The pharmaceutical industry has been one of the fastest growing segments of the Indian manufacturing sector with an average annual growth rate. India has the worlds third largest active pharmaceutical ingredients (API) for the industry valued. There is very wide scope and good market potential of products manufactured in this sector. Capacity : 90,00,000 Nos/Annum Brufen Tablets 9,00,000 Nos/Annum Paracetamol Syrup 12,00,000 Nos/Annum Dextrose Saline (In Bottles) 18,00,000 Nos/Annum Streptomycin Injection 90,00,000 Nos/Annum Vitamin Capsules
Plant capacity: -Plant & machinery: 127 Lakhs
Working capital: -T.C.I: Cost of Project : 394 Lakhs
Return: 42.00%Break even: 58.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 8 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top